awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q31160251-CEC67BF2-AC8E-4860-8781-D8F8ACFC2643
Q31160251-CEC67BF2-AC8E-4860-8781-D8F8ACFC2643
BestRank
Statement
http://www.wikidata.org/entity/statement/Q31160251-CEC67BF2-AC8E-4860-8781-D8F8ACFC2643
Failure of a systemic lupus erythematosus response index developed from clinical trial data: lessons examined and learned.
P2860
Q31160251-CEC67BF2-AC8E-4860-8781-D8F8ACFC2643
BestRank
Statement
http://www.wikidata.org/entity/statement/Q31160251-CEC67BF2-AC8E-4860-8781-D8F8ACFC2643
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
87f719e9a04e2f70e0f3324523aa85a9bf8b9312
P2860
A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-α) in patients with systemic lupus erythematosus (ROSE).